Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
6
×
clinical trials
6
×
deals
6
×
life sciences
national blog main
national top stories
rna interference
6
×
fda
alnylam pharmaceuticals
biotech
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
national
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
alexion pharmaceuticals
arrowhead pharmaceuticals
boehringer ingelheim
boston
chris collins
What
bio
drug
medicines
roundup
deal
dicerna
fda
gene
long
pharma
rnai
abandoning
acquire
ago
agreed
alliance
alzheimer’s
aren’t
baggage
billion
brings
bristol
buy
calls
cash
caught
causing
changing
cholesterol
color
companies
company
compound
congress
crispr
cuts
days
democrats
developers
development
Language
unset
Current search:
deals
×
" boston top stories "
×
" clinical trials "
×
" rna interference "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More